{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:17:04Z","timestamp":1793621824294,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2334-7-147","type":"journal-article","created":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T07:13:05Z","timestamp":1198221185000},"source":"Crossref","is-referenced-by-count":34,"title":["Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era"],"prefix":"10.1186","volume":"7","author":[{"given":"Paulo P","family":"Christo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirceu B","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agdemir W","family":"Aleixo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A","family":"Livramento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,21]]},"reference":[{"issue":"suppl 1","key":"590_CR1","first-page":"S8","volume":"6","author":"WG Powderly","year":"2000","unstructured":"Powderly WG: Current approaches to treatment for HIV-1 infection. J Neurovirol. 2000, 6 (suppl 1): S8-S13.","journal-title":"J Neurovirol"},{"key":"590_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.8096089","volume":"259","author":"M Piatak Jr","year":"1993","unstructured":"Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993, 259: 1749-1754. 10.1126\/science.8096089.","journal-title":"Science"},{"key":"590_CR3","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","volume":"271","author":"AS Perelson","year":"1996","unstructured":"Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996, 271: 1582-186. 10.1126\/science.271.5255.1582.","journal-title":"Science"},{"key":"590_CR4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","volume":"126","author":"JW Mellors","year":"1997","unstructured":"Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR: Plasma viral load and CD4 + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997, 126: 946-954.","journal-title":"Ann Intern Med"},{"key":"590_CR5","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/00002030-199714000-00010","volume":"11","author":"HR Brodt","year":"1997","unstructured":"Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB: Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS. 1997, 11: 1731-1738. 10.1097\/00002030-199714000-00010.","journal-title":"AIDS"},{"key":"590_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1750-3639.2003.tb00010.x","volume":"13","author":"O Lambotte","year":"2003","unstructured":"Lambotte O, Kumaran D, Tardieu M: HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era. Brain Pathol. 2003, 13: 95-103.","journal-title":"Brain Pathol"},{"key":"590_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1080\/13550280390194073","volume":"9","author":"AV Albright","year":"2003","unstructured":"Albright AV, Samantha SS, Gonz\u00e1lez-Scarano F: Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol. 2003, 9: 222-227. 10.1080\/713831483.","journal-title":"J Neurovirol"},{"issue":"2","key":"590_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/13550280290049615","volume":"8","author":"N Sacktor","year":"2002","unstructured":"Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L: HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002, 8 (2): 136-142.","journal-title":"J Neurovirol"},{"key":"590_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00126334-200210010-00007","volume":"31","author":"JK Neuenburg","year":"2002","unstructured":"Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W: HIV-1 related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002, 31: 171-177.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"590_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ana.10827","volume":"55","author":"A d'Arminio Monforte","year":"2004","unstructured":"d'Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, Katlama C, Justesen US, Vella S, Kirk O, Lundgren J, EuroSIDA Study Group: Changing incidence of central nervous system disease in the EuroSIDA cohort. Ann Neurol. 2004, 55 (3): 320-328. 10.1002\/ana.10827.","journal-title":"Ann Neurol"},{"key":"590_CR11","doi-asserted-by":"crossref","unstructured":"Sackor N: The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol. 2002, 115-121. 10.1080\/13550280290101094. suppl 2","DOI":"10.1080\/13550280290101094"},{"issue":"2","key":"590_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1590\/S0037-86822006000200002","volume":"39","author":"JF Oliveira","year":"2006","unstructured":"Oliveira JF, Greco DB, Oliveira GC, Christo PP, Guimar\u00e3oes MDC, Oliveira RC: Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience. Rev Soc Bras Med Trop. 2006, 39 (2): 146-151. 10.1590\/S0037-86822006000200002.","journal-title":"Rev Soc Bras Med Trop"},{"key":"590_CR13","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/00002030-199710001-00009","volume":"11","author":"G Pialoux","year":"1997","unstructured":"Pialoux G, Fournier S, Moulignier A, A Poveda J-D, Clavel F, Dupont B: Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir [letter]. AIDS. 1997, 11: 1302-1303.","journal-title":"AIDS"},{"key":"590_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.7326\/0003-4819-125-4-199608150-00001","volume":"125","author":"T Schacker","year":"1996","unstructured":"Schacker T, Collier AC, Hughes J, Shea T, Corey L: Clinical en epidemiologic features of primary HIV infection. Ann Intern Med. 1996, 125: 257-264.","journal-title":"Ann Intern Med"},{"key":"590_CR15","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/00002030-200209270-00003","volume":"16","author":"A Antinori","year":"2002","unstructured":"Antinori A, Giancola ML, Grisetti S, Soldani F, Alba L, Liuzzi G, Amendola A, Capobianchi M, Tozzi V, Perno CF: Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1 infected patients. AIDS. 2002, 16: 1867-1876. 10.1097\/00002030-200209270-00003.","journal-title":"AIDS"},{"key":"590_CR16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1086\/313810","volume":"30","author":"G Tambussi","year":"2000","unstructured":"Tambussi G, Gori A, Capiluppi B, Balotta C, Papagno L, Morandini B, Di Pietro M, Ciuffreda D, Saracco A, Lazzarin A: Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis. 2000, 30: 962-965. 10.1086\/313810.","journal-title":"Clin Infect Dis"},{"key":"590_CR17","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/JCM.30.7.1768-1771.1992","volume":"30","author":"F Chiodi","year":"1992","unstructured":"Chiodi F, Keys B, Albert J, Hagberg L, Lundeberg J, Uhlen M, Fenyo EM, Norkrans G: Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol. 1992, 30: 1768-1771.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"590_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00002030-198804000-00003","volume":"2","author":"AB Sonnerborg","year":"1988","unstructured":"Sonnerborg AB, Ehrnst AC, Bergdahl SK, Pehrson PO, Skoldenberg BR, Strannegard OO: HIV isolation from cerebrospinal fluid in relation in immunological deficiency and neurological symptoms. AIDS. 1988, 2 (2): 89-93.","journal-title":"AIDS"},{"key":"590_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/13550280390194109","volume":"9","author":"JC McArthur","year":"2003","unstructured":"McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N: Human immunodeficiency virus-associated dementia: An evolving disease. J Neurovirol. 2003, 9: 205-221. 10.1080\/713831484.","journal-title":"J Neurovirol"},{"key":"590_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1212\/01.WNL.0000058768.73358.1A","volume":"60","author":"CM Marra","year":"2003","unstructured":"Marra CM, Lockhart D, Zunt JR, Perrin M, Coombs RW, Collier AC: Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology. 2003, 60: 1388-1390.","journal-title":"Neurology"},{"key":"590_CR21","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1212\/WNL.41.6.778","volume":"41","author":"Working Group of America Academy of Neurology AIDS Task Force","year":"1991","unstructured":"Working Group of America Academy of Neurology AIDS Task Force: Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1(HIV-1) infection. Neurology. 1991, 41: 778-785.","journal-title":"Neurology"},{"key":"590_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410420504","volume":"42","author":"JC McArthur","year":"1997","unstructured":"McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER: Relationship between human immunodeficiency virus-associated dementia and viral in cerebrospinal fluid and brain. Ann Neurol. 1997, 42: 689-698. 10.1002\/ana.410420504.","journal-title":"Ann Neurol"},{"key":"590_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.410420503","volume":"42","author":"RJ Ellis","year":"1997","unstructured":"Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA: Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol. 1997, 42: 679-688. 10.1002\/ana.410420503.","journal-title":"Ann Neurol"},{"key":"590_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1086\/514001","volume":"175","author":"BJ Brew","year":"1997","unstructured":"Brew BJ, Pemberton L, Cunningham P, Law MG: Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis. 1997, 175: 963-966.","journal-title":"J Infect Dis"},{"key":"590_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/517379","volume":"177","author":"L Morris","year":"1998","unstructured":"Morris L, Silber E, Sonnenberg P, Eintracht S, Nyoka S, Lyons SF, Saffer D, Koornhof H, Martin DJ: High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid of patients with lymphocytic meningitis. J Infect Dis. 1998, 177: 473-476.","journal-title":"J Infect Dis"},{"key":"590_CR26","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/infdis\/161.6.1068","volume":"161","author":"S Shaunak","year":"1990","unstructured":"Shaunak S, Albright RE, Klotman ME, Henry SC, Bartlett JA: Hamilton JD. Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. J Infect Dis. 1990, 161: 1068-1072.","journal-title":"J Infect Dis"},{"key":"590_CR27","first-page":"777","volume":"7","author":"P Schmid","year":"1994","unstructured":"Schmid P, Conrad A, Syndulko K, Singer EJ, Handley D, Li X, Tao G, Fahy-Chandon B, Tourtellotte WW: Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr. 1994, 7: 777-788.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"590_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/00042560-199803010-00005","volume":"17","author":"C Martin","year":"1998","unstructured":"Martin C, Albert J, Hansson P, Pehrsson P, Link H, S\u00f6nnerborg A: Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 17 (3): 214-219.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"590_CR29","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1086\/520301","volume":"26","author":"P Bossi","year":"1998","unstructured":"Bossi P, Dupin N, Coutellier A, Bricaire F, Lubetzki C, Katlama C, Calvez V: The level of human immunodeficiency virus (HIV) type I RNA in cerebrospinal fluid as a marker of HIV encephalitis. Clin Infect Dis. 1998, 26: 1072-1073. 10.1086\/520301.","journal-title":"Clin Infect Dis"},{"key":"590_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00126334-199908010-00003","volume":"21","author":"M Gissl\u00e9n","year":"1999","unstructured":"Gissl\u00e9n M, Fuchs D, Svennerholm B, Hagberg L: Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr. 1999, 21: 271-276.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"590_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00042560-199512000-00005","volume":"10","author":"AJ Conrad","year":"1995","unstructured":"Conrad AJ, Schmid P, Syndulko K, Singer EJ, Nagra RM, Russell JJ, Tourtellotte WW: Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retroviral. 1995, 10 (4): 425-435.","journal-title":"J Acquir Immune Defic Syndr Hum Retroviral"},{"key":"590_CR32","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1128\/JCM.39.4.1612-1614.2001","volume":"39","author":"P Spearman","year":"2001","unstructured":"Spearman P, Fiscus SA, Smith RM, Shepard R, Johnson B, Nicotera J, Harris VL, Clough LA, McKinsey J, Haas DW: Comparison of Roche MONITOR and Organon Teknika Nuclisens Assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluid. J Clin Microbiol. 2001, 39: 1612-1614. 10.1128\/JCM.39.4.1612-1614.2001.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"590_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1067\/mpd.2002.125007","volume":"141","author":"C McCoig","year":"2002","unstructured":"McCoig C, Castrejon MM, Castano E, De Suman O, Baez C, Redondo W, McClernon D, Danehower S, Lanier ER, Richardson C, Keller A, Hetherington S, Saez-Llorens X, Ramilo O: Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy. J Pediatr. 2002, 141 (1): 36-44. 10.1067\/mpd.2002.125007.","journal-title":"J Pediatr"},{"key":"590_CR34","first-page":"S95","volume":"6 Suppl 1","author":"P Cinque","year":"2000","unstructured":"Cinque P, Bestetti A, Morelli P, Presti S: Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of central nervous system. J Neurovirol. 2000, 6 Suppl 1 (): S95-S102.","journal-title":"J Neurovirol"},{"issue":"4","key":"590_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/003655400750044926","volume":"32","author":"M Gisslen","year":"2000","unstructured":"Gisslen M, Svennerholm B, Norkrans G, Franzen C, Sall C, Svensson R, Oberg S, Hagberg L: Cerebrospinal fluid and plasma viral load in HIV-1 infected patients with various anti-retroviral treatment regiments. Scand J Infect Dis. 2000, 32 (4): 365-369. 10.1080\/003655400750044926.","journal-title":"Scand J Infect Dis"},{"issue":"12","key":"590_CR36","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/00002030-199908200-00008","volume":"13","author":"F Garcia","year":"1999","unstructured":"Garcia F, Niebla G, Romeu J, Vidal C, Plana M, Ortega M, Ruiz L, Gallart T, Clotet B, Miro JM, Pumarola T, Gatell JM: Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication. AIDS. 1999, 13 (12): 1491-1496. 10.1097\/00002030-199908200-00008.","journal-title":"AIDS"},{"key":"590_CR37","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1089\/088922203771881185","volume":"12","author":"ML Giancola","year":"2003","unstructured":"Giancola ML, Uccella I, Alba L, Lorenzini P, Soldani F, Capobianchi M, Ruco L, Perno CF, Antinori A: HIV type 1 replication in cerebrospinal fluid of patients with AIDS-related non-Hodgkin's lymphoma receiving chemotherapy and antiretroviral therapy. AIDS Res Hum Retroviruses. 2003, 12: 1091-1095. 10.1089\/088922203771881185.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"590_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF01716081","volume":"24","author":"A Lafeuillade","year":"1996","unstructured":"Lafeuillade A, Poggi C, Pellegrino P, Corti K, Profizi N, Sayada C: HIV-1 replication in the plasma and cerebrospinal fluid. Infection. 1996, 24: 367-371. 10.1007\/BF01716081.","journal-title":"Infection"},{"key":"590_CR39","first-page":"113","volume":"2","author":"DM Burger","year":"1997","unstructured":"Burger DM, Boucher CA, Meenhorst PL, Kraayeveld CL, Portegies P, Mulder JW, Hoetelmans RM, Beijnen JH: HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier. Antiviral Therapy. 1997, 2: 113-117.","journal-title":"Antiviral Therapy"},{"key":"590_CR40","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.59.3.342","volume":"59","author":"A De Luca","year":"2002","unstructured":"De Luca A, Ciancio BC, Larussa D, Murri R, Cingolani A, Rizzo MG, Giancola ML, Ammassari A, Ortona L: Correlates of independent HIV-1 replication in the CNS and of its control by retrovirals. Neurology. 2002, 59: 342-347.","journal-title":"Neurology"},{"key":"590_CR41","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1086\/319602","volume":"32","author":"RH Enting","year":"2001","unstructured":"Enting RH, Prins JM, Jurriaans S, Brinkman K, Portegies P, Lange JMA: Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid antiretroviral treatment initiated during primary HIV-1 infection. Clin Infects Dis. 2001, 32: 1095-1099. 10.1086\/319602.","journal-title":"Clin Infects Dis"},{"key":"590_CR42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2334-5-98","volume":"5","author":"SS Spudich","year":"2005","unstructured":"Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG, Paxinos EE, Price RW: Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and antiretroviral treatment. BMC Infec Dis. 2005, 5: 98-10.1186\/1471-2334-5-98.","journal-title":"BMC Infec Dis"},{"key":"590_CR43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/108729103322494302","volume":"17","author":"K Sperber","year":"2003","unstructured":"Sperber K, Shao L: Neurological consequences of HIV infection in the era of HAART. AIDS Patient Care STDS. 2003, 17: 509-518. 10.1089\/108729103322494302.","journal-title":"AIDS Patient Care STDS"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-7-147\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T20:11:03Z","timestamp":1588191063000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-7-147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-7-147","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]},"article-number":"147"}}